Clinical Trial Update: RESTORE TRIAL: A Phase 2 Study Evaluating the Efficacy and Safety of Pemvidutide in the Treatment of Alcohol-Associated Liver Disease (ALD) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of Pemvidutide for alcohol-associated liver disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol-associated Liver Disease

Drugs mentioned

• Pemvidutide (Pemvidutide)

Snippet

Sponsor: Altimmune, Inc. | Conditions: Alcohol Liver Disease | Phase 2 | Status: RECRUITING